Align Technology (ALGN) Stock Price, News & Analysis

Company Overview

Align Technology, Inc. designs, manufactures, and markets Invisalign clear aligners, and iTero intraoral scanners and services for orthodontists and general practitioner dentists in the United States, Switzerland, and internationally. The company's Clear Aligner segment offers comprehensive products, including Invisalign comprehensive package that addresses the orthodontic needs of younger patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of six and ten years, which is a mixture of primary/baby and permanent teeth. The segment also provides Invisalign moderate, lite and express packages, and Invisalign go and Invisalign Go Plus; retention products, Invisalign training, and adjusting tools used by dental professionals during the course of treatment; and Invisalign Palatal Expander, a 3D printed orthodontic device; and 3D printing solutions. Its Imaging Systems and CAD/CAM Services segment offers iTero intraoral scanning system, a single hardware platform for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and orthodontists software for digital records storage, orthodontic diagnosis, and fabrication of printed models and retainers. This segment also provides Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; Align Oral Health Suite, a digital interface designed to enhance dental consultations; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan, as well as subscription software, disposables, rentals, leases, pay per scan, and CAD/CAM software solutions. The company was incorporated in 1997 and is headquartered in Tempe, Arizona.

Key Stats

• Today's Range: $137.92 to $141.51
• 50-Day Range: $129.01 to $207.19
• 52-Week Range: $127.70 to $262.87
• Volume: 2.02 million shs
• Average Volume: 2.07 million shs
• Market Capitalization: $10.12 billion
• P/E Ratio: 23.55
• Dividend Yield: N/A
• Price Target: $215.00
• Consensus Rating: Moderate Buy

Align Technology Stock Analysis - MarketRank™

Align Technology scored higher than 99% of companies evaluated by MarketBeat, and ranked 37th out of 1,836 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 4.3 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Align Technology has received a consensus rating of Moderate Buy. The company's average rating score is 2.60, and is based on 8 buy ratings, 5 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Align Technology has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 12.16%

Earnings Growth

Earnings for Align Technology are expected to grow by 12.16% in the coming year, from $7.98 to $8.95 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Align Technology is 23.55, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 27.83.

Price to Earnings Ratio vs. Sector

The P/E ratio of Align Technology is 23.55, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 28.88.

Price to Earnings Growth Ratio

Align Technology has a PEG Ratio of 1.55. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Align Technology has a P/B Ratio of 2.59. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 4.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

4.04% of the float of Align Technology has been sold short.

Short Interest Ratio / Days to Cover

Align Technology has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Align Technology has recently decreased by 2.49%, indicating that investor sentiment is improving.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Align Technology does not currently pay a dividend.

Dividend Growth

Align Technology does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 3.8 / 5
• Environmental Score: -1.34

Percentage of Shares Shorted

4.04% of the float of Align Technology has been sold short.

Short Interest Ratio / Days to Cover

Align Technology has a short interest ratio ("days to cover") of 2.9, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Align Technology has recently decreased by 2.49%, indicating that investor sentiment is improving.

News and Social Media

• Score: 2.9 / 5
• News Sentiment: 0.19

News Sentiment

Align Technology has a news sentiment score of 0.19. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.46 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 68 news articles for Align Technology this week, compared to 15 articles on an average week.

Search Interest

15 people have searched for ALGN on MarketBeat in the last 30 days. This is an increase of 400% compared to the previous 30 days.

MarketBeat Follows

8 people have added Align Technology to their MarketBeat watchlist in the last 30 days. This is an increase of 700% compared to the previous 30 days.

Company Ownership

• Score: 3.3 / 5
• Insider Trading: Acquiring Shares

Insider Buying vs. Insider Selling

In the past three months, Align Technology insiders have bought more of their company's stock than they have sold. Specifically, they have bought $996,168.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

Only 0.66% of the stock of Align Technology is held by insiders.

Percentage Held by Institutions

88.43% of the stock of Align Technology is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

ALGN Stock Analysis - Frequently Asked Questions

How have ALGN shares performed this year?

Align Technology's stock was trading at $208.51 at the beginning of the year. Since then, ALGN shares have decreased by 33.0% and is now trading at $139.65.

How were Align Technology's earnings last quarter?

Align Technology, Inc. (NASDAQ:ALGN) posted its earnings results on Wednesday, July, 30th. The medical equipment provider reported $2.49 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $2.57 by $0.08. Align Technology's revenue was down 1.6% compared to the same quarter last year.
Read the conference call transcript.

Is Align Technology doing a stock buyback?

Align Technology's Board of Directors initiated a share repurchase program on Tuesday, August 5th 2025, which authorizes the company to repurchase $200,000,000 in outstanding shares, according to EventVestor. This means that the company could purchase up to 2% of its stock through open market purchases. Stock buyback programs are typically a sign that the company's management believes its stock is undervalued.

Does Align Technology have any subsidiaries?

Align Technology subsidiaries include exocad Global Holdings GmbH (“exocad”), G.L. Dental Couture, Cadent, and Align Technology Switzerland GmbH.

Who are Align Technology's major shareholders?

Align Technology's top institutional shareholders include Ninety One UK Ltd (2.64%), Navera Investment Management Ltd. (1.09%), Bank of New York Mellon Corp (0.97%) and Nordea Investment Management AB (0.88%). Insiders that own company stock include Joseph M Hogan, Joseph Lacob, Warren S Thaler, C Raymond Larkin Jr, Kevin J Dallas, John Morici and Emory Wright.
View institutional ownership trends.

How do I buy shares of Align Technology?

Shares of ALGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Align Technology own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Align Technology investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Netflix (NFLX), Tesla (TSLA), Visa (V) and PayPal (PYPL).

Company Calendar

• Last Earnings: 7/30/2025
• Today: 8/05/2025
• Next Earnings (Estimated): 10/22/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED/DENTAL - SUPP
• Sub-Industry: Health Care Supplies
• Current Symbol: NASDAQ:ALGN
• CIK: 1097149
• Web: www.aligntech.com
• Phone: (602) 742-2000
• Fax: 408-470-1010
• Employees: 20,945
• Year Founded: 1997

Price Target and Rating

• Average Price Target for Align Technology: $215.00
• High Price Target: $280.00
• Low Price Target: $154.00
• Potential Upside/Downside: +54.0%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.60
• Research Coverage: 15 Analysts

Profitability

• EPS (Trailing Twelve Months): $5.93
• Trailing P/E Ratio: 23.55
• Forward P/E Ratio: 17.50
• P/E Growth: 1.55
• Net Income: $421.36 million
• Net Margins: 11.04%
• Pretax Margin: 15.65%
• Return on Equity: 13.36%
• Return on Assets: 8.32%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.23
• Quick Ratio: 1.10

Sales & Book Value

• Annual Sales: $4.00 billion
• Price / Sales: 2.53
• Cash Flow: $9.11 per share
• Price / Cash Flow: 15.33
• Book Value: $53.98 per share
• Price / Book: 2.59

Miscellaneous

• Outstanding Shares: 72,490,000
• Free Float: 72,007,000
• Market Cap: $10.12 billion
• Optionable: Optionable
• Beta: 1.61